Sector Gamma ASA
Latest statistics and disclosures from Sector Gamma As's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BMY, MRK, MDT, PFE, INCY, and represent 30.55% of Sector Gamma As's stock portfolio.
- Added to shares of these 10 stocks: TMO (+$17M), REGN (+$9.8M), IQV (+$7.3M), ASND (+$5.7M), MDT (+$5.6M), ABT (+$5.4M), GEHC (+$5.2M), BSX (+$5.2M), QGEN, TVTX.
- Started 7 new stock positions in CYTK, REGN, TMO, TVTX, ASND, BSX, NTLA.
- Reduced shares in these 10 stocks: , BIIB (-$7.8M), AMGN (-$7.6M), GILD (-$7.4M), LNTH (-$7.1M), BRKR (-$6.1M), BMY (-$5.9M), MRK (-$5.6M), Ascendis Pharma A S, CAH.
- Sold out of its positions in ARWR, Ascendis Pharma A S, BBIO, COGT, DNLI, GILD, HUM, LNTH, UNH.
- Sector Gamma As was a net buyer of stock by $11M.
- Sector Gamma As has $461M in assets under management (AUM), dropping by 8.85%.
- Central Index Key (CIK): 0001475373
Tip: Access up to 7 years of quarterly data
Positions held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 40 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 9.1 | $42M | -12% | 726k | 57.62 |
|
| Merck & Co (MRK) | 6.0 | $28M | -16% | 217k | 128.50 |
|
| Medtronic SHS (MDT) | 6.0 | $28M | +25% | 352k | 78.23 |
|
| Pfizer (PFE) | 5.2 | $24M | -7% | 1.0M | 24.08 |
|
| Incyte Corporation (INCY) | 4.2 | $19M | -14% | 171k | 113.36 |
|
| Anthem (ELV) | 3.7 | $17M | 45k | 386.73 |
|
|
| BioMarin Pharmaceutical (BMRN) | 3.7 | $17M | +22% | 295k | 57.22 |
|
| Thermo Fisher Scientific (TMO) | 3.7 | $17M | NEW | 34k | 501.36 |
|
| CVS Caremark Corporation (CVS) | 3.5 | $16M | +14% | 155k | 103.45 |
|
| Iqvia Holdings (IQV) | 3.3 | $15M | +93% | 78k | 193.22 |
|
| Ionis Pharmaceuticals (IONS) | 3.3 | $15M | +11% | 190k | 79.29 |
|
| Becton, Dickinson and (BDX) | 3.1 | $14M | +12% | 93k | 151.33 |
|
| Abbott Laboratories (ABT) | 2.9 | $13M | +68% | 147k | 90.74 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 2.9 | $13M | +64% | 208k | 64.01 |
|
| Zimmer Holdings (ZBH) | 2.7 | $12M | -8% | 142k | 86.09 |
|
| Biogen Idec (BIIB) | 2.5 | $12M | -39% | 54k | 216.06 |
|
| Qiagen Nv Ord Shares (QGEN) | 2.4 | $11M | +77% | 288k | 39.10 |
|
| Centene Corporation (CNC) | 2.3 | $10M | 162k | 64.19 |
|
|
| Regeneron Pharmaceuticals (REGN) | 2.1 | $9.8M | NEW | 16k | 623.54 |
|
| Bio Rad Labs Cl A (BIO) | 2.1 | $9.8M | +40% | 33k | 293.61 |
|
| Cardinal Health (CAH) | 2.1 | $9.7M | -25% | 41k | 237.56 |
|
| Amgen (AMGN) | 2.1 | $9.5M | -44% | 26k | 362.12 |
|
| Bruker Corporation (BRKR) | 2.0 | $9.2M | -40% | 152k | 60.18 |
|
| Avantor (AVTR) | 1.9 | $9.0M | +30% | 906k | 9.90 |
|
| Ptc Therapeutics I (PTCT) | 1.8 | $8.2M | +33% | 100k | 81.57 |
|
| Labcorp Holdings Com Shs (LH) | 1.6 | $7.3M | +36% | 26k | 280.00 |
|
| Dex (DXCM) | 1.5 | $6.9M | +81% | 102k | 67.35 |
|
| Ascendis Pharma A/s Ord Shs (ASND) | 1.2 | $5.7M | NEW | 21k | 266.72 |
|
| Edwards Lifesciences (EW) | 1.2 | $5.5M | 60k | 90.46 |
|
|
| Syndax Pharmaceuticals (SNDX) | 1.1 | $5.3M | -15% | 242k | 21.86 |
|
| Boston Scientific Corporation (BSX) | 1.1 | $5.2M | NEW | 121k | 42.68 |
|
| Kura Oncology (KURA) | 1.0 | $4.8M | +5% | 433k | 10.97 |
|
| Travere Therapeutics (TVTX) | 1.0 | $4.5M | NEW | 80k | 56.81 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.9 | $4.3M | +21% | 115k | 37.42 |
|
| Tandem Diabetes Care Com New (TNDM) | 0.9 | $4.0M | 267k | 15.09 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.9 | $4.0M | +7% | 969k | 4.16 |
|
| Cytokinetics Com New (CYTK) | 0.8 | $3.8M | NEW | 45k | 85.19 |
|
| Organon & Co Common Stock (OGN) | 0.8 | $3.7M | -27% | 271k | 13.54 |
|
| Ardelyx (ARDX) | 0.8 | $3.5M | +33% | 687k | 5.10 |
|
| Intellia Therapeutics (NTLA) | 0.7 | $3.1M | NEW | 185k | 16.92 |
|
Past Filings by Sector Gamma As
SEC 13F filings are viewable for Sector Gamma As going back to 2010
- Sector Gamma As 2026 Q2 filed Aug. 12, 2026
- Sector Gamma As 2026 Q1 filed May 7, 2026
- Sector Gamma As 2025 Q4 filed Feb. 12, 2026
- Sector Gamma As 2025 Q3 filed Oct. 31, 2025
- Sector Gamma As 2025 Q2 filed July 31, 2025
- Sector Gamma As 2025 Q1 filed May 13, 2025
- Sector Gamma As 2024 Q4 filed Feb. 11, 2025
- Sector Gamma As 2024 Q3 filed Nov. 13, 2024
- Sector Gamma As 2024 Q2 filed Aug. 9, 2024
- Sector Gamma As 2024 Q1 filed May 8, 2024
- Sector Gamma As 2023 Q4 filed Feb. 5, 2024
- Sector Gamma As 2023 Q3 filed Nov. 6, 2023
- Sector Gamma As 2023 Q2 filed Aug. 9, 2023
- Sector Gamma As 2023 Q1 filed May 12, 2023
- Sector Gamma As 2022 Q4 restated filed Feb. 8, 2023
- Sector Gamma As 2022 Q4 filed Feb. 7, 2023